Safety of mogamulizumab for relapsed ATL after allogeneic hematopoietic cell transplantation

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Bone marrow transplantation (Basingstoke) 2019-02, Vol.54 (2), p.338-342
Hauptverfasser:	Inoue, Yoshitaka, Endo, Shinya, Matsuno, Naofumi, Kikukawa, Yoshitaka, Shichijo, Takafumi, Koga, Kenichi, Takaki, Ayumi, Iwanaga, Kouta, Nishimura, Nao, Fuji, Shigeo, Fukuda, Takahiro, Nosaka, Kisato, Matsuoka, Masao
Format:	Artikel
Sprache:	eng
Schlagworte:	13/31 692/699/1541/1990/291/1621/1916 692/700/565/1436/2185 Antibodies, Monoclonal, Humanized - therapeutic use Cancer Care and treatment Cell Biology Correspondence Development and progression Female Graft vs Host Disease - etiology Health aspects Hematology Hematopoietic stem cell transplantation Hematopoietic Stem Cell Transplantation - adverse effects Hematopoietic Stem Cell Transplantation - methods Humans Internal Medicine Leukemia Leukemia-Lymphoma, Adult T-Cell - complications Leukemia-Lymphoma, Adult T-Cell - pathology Leukemia-Lymphoma, Adult T-Cell - therapy Lymphomas Male Medicine Medicine & Public Health Methods Middle Aged Monoclonal antibodies Non-Hodgkin's lymphomas Patient outcomes Public Health Recurrence Stem cell transplantation Stem Cells Surgery T cells T-Lymphocytes, Regulatory - drug effects Time Factors Transplantation Transplantation, Homologous Treatment Outcome Tumors
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!